2 results
Approved WMOCompleted
Primary aim:A comparison of a hybrid CGC with planar lymphoscintigraphy in SN detection for breast cancer. Secondary aims:- A comparison of a hybrid CGC with an intraoperative gamma probe in SN detection in breast cancer. - To study if it is…
Approved WMOCompleted
Primary ObjectivesTo assess the safety of 2 fixed doses of EVP-6124 (2 or 3 mg daily) for up to 52 weeks in subjects withAlzheimer*s disease (AD) who complete (Day 182) studies EVP-6124-024 or EVP-6124-025Secondary ObjectivesTo assess the duration…